Analysts target Nedbank stock at ZAR 327.18: Nedbank receives NCBA approval

Published on 10/13/2026 at 04:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Nedbank's H1 2026 revenue rose 6.30 percent to ZAR 38.24 billion. For Nedbank stock, ROE was 15.00 percent and CET1 12.60 percent.

Nedbank received regulatory approval for its planned 66 percent acquisition of NCBA Group in Kenya.
The NCBA transaction is valued at USD 855 million to USD 856 million and would expand Nedbank's East African platform.
H1 2026 revenue rose 6.30 percent to ZAR 38.24 billion, while return on equity was 15.00 percent.
Sell-side targets cited by Stocksentinel reached ZAR 319.31 to ZAR 327.18 after the interim results.

Nedbank, ZAE000004875, Illustration mit AI erstellt.

Analysts target Nedbank stock at up to ZAR 327.18, while Nedbank received approval for its planned NCBA transaction. Stocksentinel cited sell-side targets of ZAR 319.31 to ZAR 327.18 after Nedbank's interim results, while Tech-ish reported on October 6, 2026 that the Central Bank of Kenya had approved the purchase of up to 66 percent of NCBA on August 28, 2026.

Three milestones shape the deal

On January 21, 2026, Nedbank announced an offer for approximately 66 percent of NCBA's publicly listed shares, according to the Nedbank investor-relations page. BusinessDay later valued the transaction at USD 855 million to USD 856 million and described it as the largest pure banking deal in its review of East African transactions.

On August 4, 2026, Nedbank published interim results for the six months ended June 30, 2026. The bank reported H1 2026 revenue of ZAR 38.24 billion, up 6.30 percent from ZAR 35.98 billion, while headline earnings reached ZAR 8.41 billion.

What does the transaction add?

NCBA would give Nedbank a platform spanning Kenya, Rwanda, Tanzania and Uganda. BusinessDay reported on October 12, 2026 that the deal combines Nedbank's corporate and investment banking capabilities with NCBA's digital and retail reach, creating a larger regional operating base.

The strategic attraction is scale, but execution remains the central variable. The transaction involves a controlling stake rather than a minority investment, so regulatory approvals, systems integration and governance alignment affect the eventual value captured by Nedbank.

Interim figures set the baseline

Nedbank's investor-relations page identifies H1 2026 as slightly ahead of expectations, with diluted headline earnings per share up 2.00 percent, or 15.00 percent excluding ETI base effects. Return on equity remained above 15.00 percent and the Common Equity Tier 1 ratio stood at 12.60 percent in H1 2026.

The same interim update listed an interim dividend of 1,052 cents per share for H1 2026. Together, the 15.00 percent return on equity and 12.60 percent capital ratio show why the acquisition is being assessed against both growth potential and balance-sheet capacity.

Next milestones remain operational

The NCBA approval dated August 28, 2026 is the latest dated regulatory milestone in the reviewed company context. Nedbank's H1 2026 results dated August 4, 2026 provide the financial baseline, while the January 21, 2026 offer sets the transaction's starting point.

For investors, the key comparison is between the ZAR 855 million to ZAR 856 million transaction value and Nedbank's existing profitability profile. The bank entered the deal with ZAR 38.24 billion of H1 revenue, 15.00 percent return on equity and 12.60 percent CET1 capital.